Results
622
Gain exposure to companies in the healthcare sector with a strong future outlook and robust financials.
622 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
ABT | US$101.26 | -1.1% | 9.6% | US$195.6b | US$111.79 | PE35.3x | E11.7% | 2.0% | ||
SYK | US$321.20 | -1.9% | 23.3% | US$137.3b | US$332.19 | PE39.8x | E10.8% | 0.9% | ||
BSXC | US$75.00 | 0% | 49.1% | US$122.7b | US$78.52 | PE67.1x | E20.9% | n/a | ||
BSX * | US$1,563.67 | -3.9% | 71.1% | US$122.7b | US$1,637.05 | PE67.1x | E20.9% | n/a | ||
BSX | US$75.00 | 0% | 49.3% | US$122.7b | US$78.52 | PE67.1x | E20.9% | n/a | ||
0HOY | US$83.11 | -0.8% | 56.5% | US$122.7b | US$87.01 | PE67.1x | E20.9% | n/a | ||
B1SX34 | US$453.60 | -1.7% | 71.1% | US$122.7b | US$474.89 | PE67.1x | E20.9% | n/a | ||
BSX | US$83.35 | -0.7% | 57.9% | US$122.7b | US$87.26 | PE67.1x | E20.9% | n/a | ||
BSX | US$73.50 | -1.3% | 46.8% | US$122.7b | US$76.95 | PE67.1x | E20.9% | n/a | ||
1065343 | US$83.18 | 0% | n/a | US$54.9b | US$87.79 | PE38.8x | E9.9% | n/a | ||
7741 | JP¥20,840.00 | 5.6% | 36.0% | JP¥7.3t | JP¥22,244.23 | PE38.1x | E11.3% | 0.5% | ||
ABC | US$201.45 | -1.4% | 17.1% | US$44.1b | US$232.80 | PE23.7x | E11.3% | 0.9% | ||
IDXX | US$462.80 | 1.6% | 11.1% | US$42.1b | US$494.04 | PE49.8x | E10.3% | n/a | ||
RMD | US$219.80 | 0.6% | 55.1% | US$35.1b | US$199.58 | PE34.4x | E11.4% | 0.9% | ||
0LNG | €28.90 | 5.4% | 56.3% | €27.5b | €27.26 | PS1.5x | E58.8% | n/a | ||
1PHIA | €29.37 | 7.4% | 60.0% | €27.5b | €27.70 | PS1.5x | E58.8% | n/a | ||
0A2M | €22.70 | 0% | 3.4% | €27.5b | €21.41 | PS1.5x | E58.8% | n/a | ||
PHIAA | €29.35 | 7.4% | 58.6% | €27.5b | €27.68 | PS1.5x | E58.8% | n/a | ||
PHIA | €29.01 | 5.5% | 56.3% | €27.5b | €27.36 | PS1.5x | E58.8% | n/a | ||
4013 | ر.س300.20 | -0.5% | 24.9% | ر.س105.1b | ر.س302.67 | PE48.3x | E14.9% | 1.4% | ||
D1EX34 | US$7.34 | -5.4% | -22.2% | US$27.0b | US$10.49 | PE40.4x | E16.5% | n/a | ||
0A4M | US$67.78 | -3.4% | -27.9% | US$27.0b | US$96.82 | PE40.4x | E16.5% | n/a | ||
DXCM | US$60.83 | -4.4% | -32.4% | US$27.0b | US$86.90 | PE40.4x | E16.5% | n/a | ||
DXCM | US$67.29 | -4.5% | -27.9% | US$27.0b | US$96.12 | PE40.4x | E16.5% | n/a |